{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:35:13Z","timestamp":1787009713897,"version":"build-2736575974"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"International Community Access to Child Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Malaria kills a child in sub-Saharan Africa every 2 min despite widely available interventions including intermittent preventive treatment in infants (IPTi). Since 2010, when World Health Organization (WHO) recommended IPTi, no country has implemented it. To our knowledge, no IPTi study has been conducted in Nigeria. Considering severity of malaria in infancy and urgency to improve malaria prevention, we proposed a study to investigate the efficacy of this intervention in reducing malarial morbidity and mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective(s)<\/jats:title>\n                    <jats:p>The aim of this was to determine the safety and efficacy of SP-IPTi in reducing the prevalence of asymptomatic malaria parasitemia and malarial-associated hospital admissions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a cluster-randomized controlled trial in 1379 infants. SP was administered alongside routine vaccinations in immunization centers randomized to intervention groups. Infants in control groups received only routine vaccines. Malarial \u2018morbidity and adverse events were monitored through passive case-detection and cross-sectional surveys\u2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>SP-IPTi was safe. There was no statistically significant difference in terms of risks of asymptomatic parasitemia at 9\u2009months, fever or hospitalization between our control and intervention groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study demonstrated that SP-IPTi had no benefit but was well tolerated. WHO and some researchers have also reported declining efficacy of SP, due to increasing drug resistance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/tropej\/fmad001","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T15:58:40Z","timestamp":1672847920000},"source":"Crossref","is-referenced-by-count":12,"title":["Cluster-randomized controlled trial of intermittent preventive treatment in infancy using sulfadoxine\u2013pyrimethamine (SP-IPTi): a pilot study in Nigeria"],"prefix":"10.1093","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6503-6416","authenticated-orcid":false,"given":"Olumide Thomas","family":"Adeleke","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Bowen University Teaching Hospital , Ogbomoso 232101, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abayomi","family":"Oyenuga","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Minnesota , Minneapolis, MN 55414, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5798-5774","authenticated-orcid":false,"given":"Tina M","family":"Slusher","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Bowen University Teaching Hospital , Ogbomoso 232101, Nigeria"},{"name":"Department of Pediatrics, University of Minnesota , Minneapolis, MN 55414, USA"},{"name":"Department of Pediatrics, Hennepin Healthcare , Minneapolis, MN 55404, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A","family":"Gbadero","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Bowen University Teaching Hospital , Ogbomoso 232101, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"2023011213045060700_fmad001-B1","author":"World Health Organization","year":"2016"},{"key":"2023011213045060700_fmad001-B2","first-page":"242","author":"WHO Global Malaria Programme","year":"2014"},{"key":"2023011213045060700_fmad001-B3"},{"key":"2023011213045060700_fmad001-B4"},{"key":"2023011213045060700_fmad001-B5","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0140-6736(00)04643-2","article-title":"Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial","volume":"357","author":"Schellenberg","year":"2001","journal-title":"Lancet"},{"key":"2023011213045060700_fmad001-B6","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0140-6736(09)61258-7","article-title":"Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials","volume":"374","author":"Aponte","year":"2009","journal-title":"Lancet"},{"key":"2023011213045060700_fmad001-B7","doi-asserted-by":"crossref","first-page":"e12223","DOI":"10.1371\/journal.pone.0012223","article-title":"Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children","volume":"5","author":"Conteh","year":"2010","journal-title":"PLoS One"},{"key":"2023011213045060700_fmad001-B8","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2217\/fmb.11.138","article-title":"Malaria treatment and prophylaxis in endemic and nonendemic countries: evidence on strategies and their cost\u2013effectiveness","volume":"6","author":"Van Vugt","year":"2011","journal-title":"Futur Microbiol"},{"key":"2023011213045060700_fmad001-B9","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S1473-3099(18)30732-1","article-title":"Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis","volume":"19","author":"Maria van Eijk","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2023011213045060700_fmad001-B10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijpddr.2016.08.004","article-title":"Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V","volume":"6","author":"Oguike","year":"2016","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"2023011213045060700_fmad001-B11","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(09)60997-1","article-title":"Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial","volume":"374","author":"Gosling","year":"2009","journal-title":"Lancet"},{"key":"2023011213045060700_fmad001-B12","first-page":"4","author":"World Health Organisation","year":"2010"},{"key":"2023011213045060700_fmad001-B13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0166-6851(97)00114-X","article-title":"Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins","volume":"89","author":"Wang","year":"1997","journal-title":"Mol Biochem Parasitol"},{"key":"2023011213045060700_fmad001-B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-4-1","article-title":"The promise and potential challenges of intermittent preventive treatment for malaria in infants (IPTi)","volume":"4","author":"O\u2019Meara","year":"2005","journal-title":"Malar J"},{"key":"2023011213045060700_fmad001-B15","doi-asserted-by":"crossref","first-page":"e12618","DOI":"10.1371\/journal.pone.0012618","article-title":"Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine- pyrimethamine and parasite resistance","volume":"5","author":"Griffin","year":"2010","journal-title":"PLoS One"},{"key":"2023011213045060700_fmad001-B16","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1086\/592455","article-title":"Rapid increase in the prevalence of sulfadoxine-pyrimethamine resistance among Plasmodium falciparum isolated from pregnant women in Ghana","volume":"198","author":"Mockenhaupt","year":"2008","journal-title":"J Infect Dis"},{"key":"2023011213045060700_fmad001-B17","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0140-6736(08)61583-4","article-title":"Intermittent preventive antimalarial treatment in infancy","volume":"372","author":"Greenwood","year":"2008","journal-title":"Lancet"},{"key":"2023011213045060700_fmad001-B18","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/de06fdd3-c263-416c-8b5f-291f9c474558","article-title":"Intermittent preventive treatment for malaria in papua new Guinean infants exposed to plasmodium falciparum and P. vivax: a randomized controlled trial","volume":"9","author":"Senn","year":"2012","journal-title":"PLoS Med"},{"key":"2023011213045060700_fmad001-B19","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/bmj.331.7519.727","article-title":"Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana","volume":"331","author":"Chandramohan","year":"2005","journal-title":"Br Med J"},{"key":"2023011213045060700_fmad001-B20","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1128\/AAC.00513-07","article-title":"Intermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, placebo-controlled trial in northern Ghana","volume":"51","author":"Mockenhaupt","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2023011213045060700_fmad001-B21","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1086\/505431","article-title":"Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial","volume":"194","author":"Macete","year":"2006","journal-title":"J Infect Dis"},{"key":"2023011213045060700_fmad001-B22","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1371\/journal.pmed.0020003","article-title":"Intermittent presumptive treatment for malaria: a better understanding of the pharmacodynamics will guide more rational policymaking","volume":"2","author":"White","year":"2005","journal-title":"PLoS Med"},{"key":"2023011213045060700_fmad001-B23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/518575","article-title":"A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants","volume":"45","author":"Kobbe","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2023011213045060700_fmad001-B24","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood.2019000944","article-title":"Glucose-6-phosphate dehydrogenase deficiency","volume":"136","author":"Luzzatto","year":"2020","journal-title":"Blood"}],"container-title":["Journal of Tropical Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/tropej\/article-pdf\/69\/1\/fmad001\/48649937\/fmad001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/tropej\/article-pdf\/69\/1\/fmad001\/48649937\/fmad001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T13:12:09Z","timestamp":1673529129000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/tropej\/article\/doi\/10.1093\/tropej\/fmad001\/6986163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12,5]]}},"URL":"https:\/\/doi.org\/10.1093\/tropej\/fmad001","relation":{},"ISSN":["1465-3664"],"issn-type":[{"value":"1465-3664","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2,1]]},"published":{"date-parts":[[2022,12,5]]},"article-number":"fmad001"}}